HUMAN GENOME SCIENCES INC (HGSI) has 38 open-market insider trades by 15 insiders since 2006. The most active filer is Thomas Watkins, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Glaxosmithkline PLC | Dir10% | — | 2 | $1.1B | 2012-08-02 |
| Susan D. Bateson | PresVP | — | 1 | $4.8M | 2012-07-30 |
| Jurgen Drews | Dir | — | 3 | $2.7M | 2011-01-10 |
| Thomas Watkins | CEO | — | 10 | $2.2M | 2012-07-30 |
| Curran Simpson | Sr. VPOperations | — | 1 | $1.3M | 2012-07-30 |
| Ngoc Tuan Ha | Dir | — | 3 | $218K | 2012-07-30 |
| Maxine Gowen | Dir | — | 1 | $216K | 2012-07-30 |
| Timothy C. Barabe | CFO | — | 8 | $209K | 2010-02-22 |
| George J. Morrow | Dir | — | 1 | $158K | 2012-07-30 |
| Argeris N. Karabelas | Dir | — | 1 | $152K | 2012-07-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Glaxosmithkline PLC | Director & 10% | Buy | $973.7M | 2012-08-01 |
| Glaxosmithkline PLC | Director & 10% | Buy | $95.8M | 2012-07-30 |
| Ngoc Tuan Ha | Director | Buy | $160K | 2011-08-05 |
| George J. Morrow | Director | Buy | $158K | 2011-08-05 |
| Colin Goddard | Director | Buy | $49K | 2011-08-04 |
| Thomas Watkins | CEO | Buy | $42K | 2011-06-30 |
Companies that share insiders with HGSI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Curran Simpson | Sr. VP & Operations | Sell | $621K | 2011-06-01 |
| James H. Davis | Exec. VP & Gen Counsel & Sec. | Sell | $260K | 2011-05-02 |
| Barry Labinger | Exec VP & CCO | Sell | $220K | 2011-05-02 |
| Curran Simpson | Sr. VP & Operations | Sell | $812K | 2011-04-29 |
| Barry Labinger | Exec VP & CCO | Sell | $1.2M | 2011-04-28 |
| Susan D. Bateson | President & VP | Sell | $90K | 2011-04-28 |
| Susan D. Bateson | President & VP | Sell | $690K | 2011-04-20 |
| James H. Davis | Exec. VP & Gen Counsel & Sec. | Sell | $1.6M | 2011-04-13 |
| Colin Goddard | Director | Buy | $75K | 2011-03-22 |